- About Us
- Press Releases
- 2014
- SCIEX expands software capability to include DiscoveryQuant™ 3.0 Software for the High Throughput Pharmaceutical Laboratory
DiscoveryQuant 3.0 Software introduced reducing LC/MS method development and optimization time for high throughput drug discovery (ADME) laboratories
Framingham, MA — SCIEX, a global leader in life science analytical technologies, today introduced DiscoveryQuant 3.0 Software, a new version of its proven ADME software that enables scientists to significantly reduce LC/MS method development and optimization time for high throughput drug discovery (ADME) laboratories focusing on both small molecules and biotherapeutics. Scientists can now make better decisions about drug candidates faster, as DiscoveryQuant 3.0 software reduces tedious LC/MS method development time with a fast, robust, and reliable process that optimizes methods for hundreds of small and/or large molecules.
DiscoveryQuant 3.0 Software expedites the method development process from existing database information, automates on-column optimization, and easily analyzes and processes multiple samples at the same time. Supported on all SCIEX MS platforms (TripleTOF®, QTRAP®, and Triple Quad™ systems) and with the ability to seamlessly communicate with MultiQuant™ 3.0 Software, DiscoveryQuant 3.0 Software ensures success in high throughput drug discovery and development.
"Discovery labs continue to search for ways to improve efficiency to address the demands of fast turn-around times required in the drug candidate screening process," said Joe Fox, Senior Director of Pharma Business at SCIEX. "Our goal is to offer best-in-class system solutions and DiscoveryQuant 3.0 software in combination with our LCMS platforms stays true to that, as it provides scientists with the ability to rapidly develop methods for all molecule types, in a high throughput environment."
In addition to reducing tedious LC/MS method development times with fast, robust and reliable processes, DiscoveryQuant 3.0 Software's offers:
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com
SCIEX social: @SCIEXnews, LinkedIn, and Facebook.
AB Sciex is operating as SCIEX.
© 2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.
For research use only. Not for use in diagnostic procedures.
Contact Information
Lulu VanZandt
Program Manager, Brand, Public Relations and Social Media, SCIEX
lulu.vanzandt@sciex.com
+1 (508) 383-7163
M: +1 (508) 782-9484